Remicade (anti tumor necrosis factor inhibitor)

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
40	Takayasu arteritis	1

40. Takayasu arteritis

Clinical trials : 24 / Drugs : 40 - (DrugBank : 18) / Drug target genes : 23 - Drug target pathways : 110

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02457585 (ClinicalTrials.gov)	March 2015	18/5/2015	Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis	Anti-tumor Necrosis Factor Therapy Effect on Takayasu Arteritis	Takayasu's Arteritis	Drug: remicade (anti tumor necrosis factor inhibitor)	Seoul National University Hospital	NULL	Recruiting	18 Years	N/A	All	11	Phase 2	Korea, Republic of

First Previous1Next Last